| |  Online-Ressource |
|---|
| Verfasst von: | Liu, Li [VerfasserIn]  |
|---|
| | An, Xuefeng [VerfasserIn] |
|---|
| | Schäfer, Michael [VerfasserIn] |
|---|
| | Yan, Bin [VerfasserIn] |
|---|
| | Torre, Carolina de la [VerfasserIn] |
|---|
| | Hillmer, Stefan [VerfasserIn] |
|---|
| | Gladkich, Jury [VerfasserIn] |
|---|
| | Herr, Ingrid [VerfasserIn] |
|---|
| Titel: | Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death |
|---|
| Verf.angabe: | Li Liu, XueFeng An, Michael Schaefer, Bin Yan, Carolina de la Torre, Stefan Hillmer, Jury Gladkich, Ingrid Herr |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 2 August 2022 |
|---|
| Umfang: | 18 S. |
|---|
| Illustrationen: | Illustrationen, Graphen |
|---|
| Fussnoten: | Gesehen am 22.12.2022 |
|---|
| Titel Quelle: | Enthalten in: Biomedicine & pharmacotherapy |
|---|
| Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1989 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 153(2022), Artikel-ID 113511, Seite 2-18 |
|---|
| ISSN Quelle: | 1950-6007 |
|---|
| Abstract: | Silver has been in clinical use since ancient times and silver nanoparticles (AgNPs) have attracted attention in cancer therapy. We investigated the mechanisms by which AgNPs inhibit pancreatic ductal adenocarcinoma (PDAC). AgNPs were synthesized and 3 human PDAC and 2 nonmalignant primary cell lines were treated with AgNPs. MTT, MAPK, colony, spheroid and scratch assays, Western blotting, TEM, annexin V, 7-AAD, and H2DCFDA staining, FACS analysis, mRNA array and bioinformatics analyses, tumor xenograft transplantation, and immunohistochemistry of the treated cells were performed. We found that minimal AgNPs amounts selectively eradicated PDAC cells within a few hours. AgNPs inhibited cell migration and spheroid and colony formation, damaged mitochondria, and induced paraptosis-like cell death with the presence of cytoplasmic vacuoles, dilation of the ER and mitochondria, ROS formation, MAPK activity, and p62 and LC3b expression, whereas effects on the nucleus, DNA fragmentation, or caspases were not detectable. AgNPs strongly decreased tumor xenograft growth without side effects and reduced the expression of markers for proliferation and DNA repair, but upregulated paraptosis markers. The results highlight nanosilver as complementary agent to improve the therapeutic efficacy in pancreatic cancer. |
|---|
| DOI: | doi:10.1016/j.biopha.2022.113511 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1016/j.biopha.2022.113511 |
|---|
| | Volltext: https://www.sciencedirect.com/science/article/pii/S0753332222009003 |
|---|
| | DOI: https://doi.org/10.1016/j.biopha.2022.113511 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Alternative Therapies |
|---|
| | Cancer Research |
|---|
| | Colloidal silver |
|---|
| | Nanosilver |
|---|
| | Pancreatic cancer |
|---|
| K10plus-PPN: | 1828829226 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death / Liu, Li [VerfasserIn]; 2 August 2022 (Online-Ressource)
Andere Auflagen/Ausgaben